WEALTHFRONT ADVISERS LLC Alnylam Pharmaceuticals, Inc. Transaction History

WEALTHFRONT ADVISERS LLC portfolio value:

$3.67M
portfolio value

WEALTHFRONT ADVISERS LLC quarter portfolio value change:

+37.24%
quarter

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +30.16% 4.25K shares 1.61M $200.16 18.37K
Q2 2022 share Increase +9.91% 1.27K shares -38K $145.85 14.11K
Q1 2022 share Increase +873.84% 11.52K shares 1.87M $163.29 12.84K
Q4 2021 share Increase 0.00% 1.31K shares 224K $171.03 1.31K